Alpha 2.0
Login Register
» Articles » PMID: 21393209

Clinical Experience of Raltegravir-containing Regimens in HIV-infected Patients During Rifampicin-containing Treatment of Tuberculosis

Overview
Journal J Antimicrob Chemother
Publisher Oxford University Press
Specialty Infectious Diseases
Date 2011 Mar 12
PMID 21393209
Citations 5
Authors
Alvaro Mena
Pilar Vazquez
Angeles Castro
Soledad Lopez
Laura Bello
Jose D Pedreira
Affiliations
Soon will be listed here.
Citing Articles

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis.

Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S AIDS Res Ther. 2016; 13:34.

PMID: 27708678 PMC: 5037900. DOI: 10.1186/s12981-016-0118-7.

Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.

Regazzi M, Carvalho A, Villani P, Matteelli A Clin Pharmacokinet. 2014; 53(6):489-507.

PMID: 24777631 DOI: 10.1007/s40262-014-0144-3.

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.

Lawn S, Meintjes G, McIlleron H, Harries A, Wood R BMC Med. 2013; 11:253.

PMID: 24295487 PMC: 4220801. DOI: 10.1186/1741-7015-11-253.

Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa.

Murphy R, Marconi V, Gandhi R, Kuritzkes D, Sunpath H PLoS One. 2012; 7(9):e44793.

PMID: 23028623 PMC: 3460963. DOI: 10.1371/journal.pone.0044793.

Raltegravir in HIV-1 infection: Safety and Efficacy in Treatment-naïve Patients.

Pandey K Clin Med Rev Ther. 2012; 2012(4):13-30.

PMID: 22389581 PMC: 3289997. DOI: 10.4137/CMRT.S5022.